| Literature DB >> 11890714 |
Atsushi Ito1, Abigail C Buenafe, Agata Matejuk, Alex Zamora, Marc Silverman, Jami Dwyer, Arthur A Vandenbark, Halina Offner.
Abstract
Estrogen treatment has been found to have suppressive activity in several models of autoimmunity. To investigate the mechanism of 17 beta-estradiol (E2) suppression of experimental autoimmune encephalomyelitis, we evaluated E2 effects on TNF-alpha expression in the central nervous system (CNS) and spleen of C57BL/6 mice immunized with MOG 35-55/CFA. Kinetic analysis demonstrated that E2 treatment drastically decreased the recruitment of total inflammatory cells as well as TNF-alpha(+) macrophages and T cells into the CNS at disease onset. In contrast, E2 had only moderate effects on the relatively high constitutive TNF-alpha expression by resident CNS microglial cells. E2 treatment also had profound inhibitory effects on expression of TNF-alpha by splenic CD4(+) T cells, including those responsive to MOG 35-55 peptide. We propose that the mechanism of E2 protection may involve both systemic inhibition of TNF-alpha expression and local (CNS) recruitment of inflammatory cells, with modest effects on TNF-alpha expression by resident CNS microglial cells.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11890714 DOI: 10.1006/clim.2001.5175
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969